Evidence map›Paper›PMID 33477819›Full record

ArticleHealthcare (Basel, Switzerland)2021

Cost Analysis of Selected Radiotherapeutic Modalities for Prostate Cancer Treatment-Czech Republic Case Study for the Purposes of Hospital Based HTA.

Petra Hospodková, Tomáš Husár, Barbora Klíčová, Lucie Severová, Karel Šrédl, Roman Svoboda

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Petra HospodkováDepartment of Economic Theories, Faculty of Economics and Management, Czech University of Life Sciences Prague, 165 00 Prague, Czech Republic.ORCID 0000-0001-6542-8196
Tomáš HusárDepartment of Biomedical Technology, Czech Technical University in Prague, 272 01 Kladno, Czech Republic.ORCID 0000-0001-9795-6073
Barbora KlíčováDepartment of Biomedical Technology, Czech Technical University in Prague, 272 01 Kladno, Czech Republic.
Lucie SeverováDepartment of Economic Theories, Faculty of Economics and Management, Czech University of Life Sciences Prague, 165 00 Prague, Czech Republic.
Karel ŠrédlDepartment of Economic Theories, Faculty of Economics and Management, Czech University of Life Sciences Prague, 165 00 Prague, Czech Republic.ORCID 0000-0002-5807-0015
Roman SvobodaDepartment of Economic Theories, Faculty of Economics and Management, Czech University of Life Sciences Prague, 165 00 Prague, Czech Republic.ORCID 0000-0003-1548-9403
Czech University of Life Sciences Prague · CZCzech Technical University in Prague · CZ

Funding

Provozně Ekonomická Fakulta, Česká Zemědělská Univerzita v Praze 2019A0009
6 · The paper itself

Abstract

This study aims to calculate the costs of prostate cancer radiotherapy in a regional hospital Department of Radiation Oncology equipped with Three-Dimensional Conformal Radiation Therapy (3D-CRT) and Intensity Modulated Radiation Therapy (IMRT) Volumetric Arc Therapy (VMAT) radiation technology, using activity based costing (ABC), and to compare the costs of both methods at the level of component treatment process activities and with respect to insurance reimbursements. The costing was performed based on a sample of 273 IMRT VMAT patients and 312 3D-CRT patients in a regional hospital in the period from 2018 to 2019. The research has highlighted the necessity to place emphasis on factors that may skew the costing results. The resulting output has been supplemented by a sensitivity analysis, whereas the modeled parameter is represented by the time required for one patient fraction on a linear accelerator and the time the Radiology Assistant needs to prepare the complete radiation plan as part of radiotherapy planning. Moreover, the effects of the received grant, in the form of calculated write-offs, are also considered. The case study uses the example of radiotherapy to demonstrate the potential of ABC and suggests considering the application of this method as an effective management tool for cost and economic evaluation as part of comprehensive hospital assessment under the Hospital-Based Health Technology Assessment (HB-HTA) initiative.

Indexed as

3D-CRTactivity based costingIMRTprostate cancersensitivity analysis

Identifiers

PMID33477819
PMCPMC7832912
OpenAlexW3126113798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.